Reducing the Number of Flexible Cystoscopies in Patients Undergoing Follow-Up for Non-Muscle Invasive Bladder Cancer with Either Flexible Cystoscopy or the Urinary Biomarker Test Bladder Cancer Monitor: A Secondary Outcome from a Randomised Clinical Trial